Skip to content

Walking Fatigability,Saptiotemporal Gait Parameters and Falling in MS Patients

Influance of Walking Fatigability on Spatiotemporal Gait Parameters and Risk of Falling in Patients With Multiple Scalerosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07524556
Acronym
WF-GAIT-FALL
Enrollment
62
Registered
2026-04-13
Start date
2026-04-01
Completion date
2026-07-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

MS, walking fatigability, gait parameters, risk of falling

Brief summary

This observational study aims to investigate the relationship between walking fatigability, changes in spatiotemporal gait parameters, and risk of falling in individuals with multiple sclerosis (MS). Participants will be divided into two groups: those with walking fatigability and those without. Each participant will undergo functional tests to detect deterioration in patiotemoral gait parameters and risk of falling . The results of this study will help understand how walking fatigability affects gait and fall risk in MS, providing insights for rehabilitation strategies.

Detailed description

Multiple sclerosis (MS) is a chronic neurological disease that often affects mobility, balance, and endurance. Walking fatigability, defined as a decline in walking performance over time, is a common problem in individuals with MS and may increase the risk of falls. Understanding how walking fatigability influences gait patterns and fall risk is essential for designing targeted rehabilitation strategies. This observational study aims to investigate the relationship between walking fatigability, spatiotemporal gait parameters, and fall risk in individuals with MS. Participants will be recruited from Alexandria University Hospital and will be divided into two groups based on the presence or absence of walking fatigability. Inclusion criteria include confirmed MS diagnosis, ability to walk independently, and willingness to provide informed consent. Exclusion criteria include acute MS relapse, comorbid conditions affecting gait, or cognitive impairment that prevents safe participation. Participants will undergo 6-Minute Walk Test to assess walking performance, and gait parameters such as step length and double time support.and gait speed will be recorded. Fall risk will be evaluated using a Timed Up and Go (TUG) test and The Falls Efficacy Scale-International (FES-I). Data will be analyzed to compare gait changes and fall risk between the two groups. Correlations between walking fatigability and specific gait parameters will be explored to identify patterns associated with higher fall risk. The findings of this study are expected to inform clinical decision-making and rehabilitation approaches, contributing to safer and more effective mobility management for individuals with MS.

Interventions

None listed

Sponsors

Ibrahim Ahmad Elmongy
Lead SponsorOTHER
Horus University
CollaboratorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Sixty-two RRMS patients from both sexes. * Aged from 20 to 40 years with a confirmed diagnosis of multiple sclerosis (based on McDonald criteria). * Ambulatory for at least 6 minutes, without the use of assistive devices. * EDSS score between 2.0 and 5.0. * no relapse within 1 month prior to participation

Exclusion criteria

* The presence of other neurological or orthopaedic conditions that could affect gait or balance. * Severe cognitive impairment (as determined by clinical history or physician report). * Active MS relapses or corticosteroid treatment within the last 30 days. * Visual or vestibular impairments that significantly interfere with gait or postural control. * Diabetic patients will be excluded as this will interfere with balance.

Design outcomes

Primary

MeasureTime frameDescription
Distance walking indexBaselinemeasurd as a decline in walking distance between first and last minute more than 10%
Spatiotemporal Gait ParametersBaselineincludes step length in meter(m) , gait velocity in meter per secound(m/s) and double time support in secounds(s) measured using gait analysis tool ( kinovea software)
Risk of FallingBaselineAssessed using fall efficacy scale- international and timed up and go test measured in secounds(s)
precived fatigueBaselineassessed by modified fatigue impact scale

Countries

Egypt

Contacts

CONTACTIbrahim Ahmed Elmongy
ibrahem.abm1@gmail.com+201061029866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026